当前位置: X-MOL 学术Drugs: Education, Prevention and Policy › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences
Drugs: Education, Prevention and Policy ( IF 2.007 ) Pub Date : 2020-12-10 , DOI: 10.1080/09687637.2020.1854688
Monnica T Williams 1, 2 , Alan K Davis 3, 4 , Yitong Xin 3 , Nathan D Sepeda 4 , Pamela Colόn Grigas 2 , Sinead Sinnott 2 , Angela M Haeny 5
Affiliation  

Abstract

This study examined how psychedelics reduced symptoms of racial trauma among black, indigenous, and people of color (BIPOC) subsequent to an experience of racism. A cross-sectional internet-based survey included questions about experiences with racism, mental health symptoms, and acute and enduring psychedelic effects. Changes in mental health were assessed by retrospective report of symptoms in the 30 days before and 30 days after an experience with psilocybin, Lysergic acid diethylamide (LSD), or 3,4-Methyl​enedioxy​methamphetamine (MDMA). We recruited 313 diverse BIPOC in the US and Canada. Results revealed a significant (p < .001) and moderate (d = −.45) reduction in traumatic stress symptoms from before-to-after the psychedelic experience. Similarly, participants reported decreases in depression (p < .001; d = −.52), anxiety (p < .001; d = −.53), and stress (p < .001; d = −.32). There was also a significant relationship (Rc = 0.52, p < .001) between the dimension of acute psychedelic effects (mystical-type, insight, and challenging experiences) and decreases in a cluster of subsequent psychopathology (traumatic stress, depression, anxiety, and stress), while controlling for the frequency of prior discrimination and the time since the psychedelic experience. BIPOC have been underrepresented in psychedelic studies. Psychedelics may decrease the negative impact of racial trauma. Future studies should examine the efficacy of psychedelic-assisted therapy for individuals with a history of race-based trauma.



中文翻译:

北美有色人种报告迷幻体验后种族创伤和心理健康症状有所改善

摘要

这项研究调查了迷幻药如何减轻黑人、土著和有色人种 (BIPOC) 在经历种族主义后的种族创伤症状。一项基于互联网的横断面调查包括有关种族主义经历、心理健康症状以及急性和持久的迷幻效果的问题。通过在使用裸盖菇素、麦角酸二乙胺 (LSD) 或 3,4-甲基二氧甲基苯丙胺 (MDMA) 之前 30 天和之后 30 天的症状回顾性报告来评估心理健康的变化。我们在美国和加拿大招募了 313 名多元化的 BIOC。结果显示,从迷幻体验之前到之后,创伤性压力症状显着(p < .001)和中度(d = -.45)减少。同样,参与者报告抑郁症有所减少(p < .001;d = -.52)、焦虑 ( p < .001; d = -.53) 和压力 ( p < .001; d = -.32)。急性致幻效应的维度(神秘类型、洞察力和挑战性经历)与一系列后续精神病理学(创伤性压力、抑郁、焦虑)的减少之间也存在显着关系(R c  = 0.52,p < .001) ,和压力),同时控制先前歧视的频率和自迷幻体验以来的时间。BIPOC 在迷幻药研究中的代表性不足。迷幻药可能会减少种族创伤的负面影响。未来的研究应该检查迷幻辅助疗法对有种族创伤史的个体的疗效。

更新日期:2020-12-10
down
wechat
bug